119 related articles for article (PubMed ID: 12557904)
1. Poly (DL-lactide-co-glycolide) based delivery systems for vaccines and drugs.
Dhiman N; Dutta M; Khuller GK
Indian J Exp Biol; 2000 Aug; 38(8):746-52. PubMed ID: 12557904
[TBL] [Abstract][Full Text] [Related]
2. Poly (DL-lactide-co-glycolide) microparticles as carriers for antimycobacterial drug rifampicin.
Dutt M; Khuller GK
Indian J Exp Biol; 2000 Sep; 38(9):887-94. PubMed ID: 12561946
[TBL] [Abstract][Full Text] [Related]
3. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
4. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment.
Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T
J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845
[TBL] [Abstract][Full Text] [Related]
5. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
[TBL] [Abstract][Full Text] [Related]
7. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
8. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
10. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
11. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.
Waeckerle-Men Y; Groettrup M
Adv Drug Deliv Rev; 2005 Jan; 57(3):475-82. PubMed ID: 15560953
[TBL] [Abstract][Full Text] [Related]
12. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
13. Aspects of the design and delivery of microparticles for vaccine applications.
Jenkins PG; Coombes AG; Yeh MK; Thomas NW; Davis SS
J Drug Target; 1995; 3(1):79-81. PubMed ID: 7655826
[TBL] [Abstract][Full Text] [Related]
14. Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.
Ahmad Z; Pandey R; Sharma S; Khuller GK
Int J Antimicrob Agents; 2008 Feb; 31(2):142-6. PubMed ID: 18155883
[TBL] [Abstract][Full Text] [Related]
15. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
[TBL] [Abstract][Full Text] [Related]
17. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
Jones DH; Partidos CD; Steward MW; Farrar GH
Behring Inst Mitt; 1997 Feb; (98):220-8. PubMed ID: 9382743
[TBL] [Abstract][Full Text] [Related]
19. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
Jain S; O'Hagan DT; Singh M
Expert Rev Vaccines; 2011 Dec; 10(12):1731-42. PubMed ID: 22085176
[TBL] [Abstract][Full Text] [Related]
20. Immunization by particle bombardment of antigen-loaded poly-(DL-lactide-co-glycolide) microspheres in mice.
Uchida M; Natsume H; Kishino T; Seki T; Ogihara M; Juni K; Kimura M; Morimoto Y
Vaccine; 2006 Mar; 24(12):2120-30. PubMed ID: 16356602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
